Michael A. Ross serves as Executive at 20/20 Biolabs, Inc., where they oversee executive responsibilities. Since joining the company, Michael A. Ross has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 19, 2026 involved exercising options for 31 shares valued at $0.
Michael A. Ross currently holds 31 shares of 20/20 Biolabs, Inc. (AIDX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael A. Ross has been a net neutral trader of AIDX stock. They have purchased $0 and sold $0 worth of shares.
Michael A. Ross's most recent insider trade was on Feb 19, 2026, when they sold 31 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |